HomeInsightsStock Comparison

Accent Microcell Ltd vs Bajaj Healthcare Ltd Stock Comparison

Accent Microcell Ltd vs Bajaj Healthcare Ltd Stock Comparison

Last Updated on: May 16, 2025

Key Highlights

  • The Latest Trading Price of Accent Microcell Ltd is ₹ 243 as of 16 May 09:57.
  • The P/E Ratio of Accent Microcell Ltd changed from 17.1 on March 2024 to 17.1 on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Bajaj Healthcare Ltd changed from 11.2 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Accent Microcell Ltd changed from ₹ 517.13 crore on March 2024 to ₹ 517.13 crore on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Bajaj Healthcare Ltd changed from ₹ 283.78 crore on March 2020 to ₹ 807.25 crore on March 2024 . This represents a CAGR of 23.26% over 5 years.
  • The revenue of Accent Microcell Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bajaj Healthcare Ltd for the Dec '24 is ₹ 125.17 crore as compare to the Sep '24 revenue of ₹ 136.82 crore. This represent the decline of -8.51%.
  • The ebitda of Accent Microcell Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bajaj Healthcare Ltd for the Dec '24 is ₹ 20.77 crore as compare to the Sep '24 ebitda of ₹ 28.25 crore. This represent the decline of -26.48%.
  • The net profit of Accent Microcell Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Bajaj Healthcare Ltd changed from ₹ -48.21 crore to ₹ 11.72 crore over 7 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Accent Microcell Ltd changed from 6.93 % on March 2021 to 6.97 % on March 2024 . This represents a CAGR of 0.14% over 4 yearsThe Dividend Payout of Bajaj Healthcare Ltd changed from 4.57 % on March 2021 to -3.29 % on March 2024 . This represents a CAGR of NaN% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Accent Microcell Ltd

  • Accent Microcell Ltd was originally incorporated on April 10, 2012 as a Private Limited Company as “Accent Microcell Private Limited” with the Registrar of Companies, Gujarat.
  • The Company converted from a Private Limited Company to Public Limited Company and , the name was changed to ‘Accent Microcell Limited’ and a Fresh Certificate of Incorporation was issued on December 23, 2022 by the Registrar of Companies, Ahmedabad. Presently, the Company manufacture Microcrystalline Cellulose (MCC) consisting Spray Dryer / Spin Flash Dried.
  • The Company is engaged in manufacturing of the high-quality cellulose-based excipients which predominantly find application in the Pharmaceutical, Nutraceutical, Food, Cosmetic and other industries. With 2 state-of-art manufacturing facilities located in Pirana (Unit -I) and Dahej SEZ (Unit -II).

About Bajaj Healthcare Ltd

  • Bajaj Healthcare Ltd. is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness.
  • The Company commenced its operations in 1993 with a single unit at Tarapur.
  • It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
  • It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities.
  • In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility.

Accent Microcell Ltd News Hub

News

Accent Microcell announces board meeting date

Accent Microcell will hold a meeting of the Board of Directors of the Company on 9 May 202...

Read more

07 May 2025 11:25

News

Accent Microcell to announce Quarterly Result

Accent Microcell will hold a meeting of the Board of Directors of the Company on 20 Novemb...

Read more

16 Nov 2024 10:07

News

Accent Microcell schedules board meeting

Accent Microcell will hold a meeting of the Board of Directors of the Company on 29 Octobe...

Read more

25 Oct 2024 15:54

News

Accent Microcell to table results

Accent Microcell will hold a meeting of the Board of Directors of the Company on 17 Octobe...

Read more

15 Oct 2024 17:34

News

Accent Microcell schedules AGM

Accent Microcell announced that the 12th Annual General Meeting (AGM) of the company will ...

Read more

06 Aug 2024 17:28

News

Board of Accent Microcell recommends final dividend

Accent Microcell announced that the Board of Directors of the Company at its meeting held ...

Read more

18 May 2024 15:41

Bajaj Healthcare Ltd News Hub

News

Bajaj Healthcare gains after acquiring WHO-GMP certified firm Genrx Pharma

The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% cont...

Read more

08 Apr 2025 13:22

News

Bajaj Healthcare to table results

Bajaj Healthcare will hold a meeting of the Board of Directors of the Company on 11 Februa...

Read more

07 Feb 2025 10:48

News

Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin in India

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI)...

Read more

30 Jan 2025 09:24

News

Bajaj Healthcare gets DGCI nod for manufacturing of Pimavanserin in India

Pimavanserin is an atypical antipsychotic used for the treatment of hallucinations and del...

Read more

30 Jan 2025 13:32

News

Bajaj Healthcare hits record high after receiving rights to manufacture Magtein in India

The company will have the rights to manufacture, market, distribute, co-market in the Indi...

Read more

17 Jan 2025 11:50

News

Bajaj Healthcare hits 52-week high on TGA nod for Vadodara unit

The approval is valid for a period of 24 months. The said site has already received approv...

Read more

09 Dec 2024 12:39

SWOT Analysis Of Accent Microcell Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Bajaj Healthcare Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Accent Microcell Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bajaj Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Accent Microcell Ltd and Bajaj Healthcare Ltd

Which company has a larger market capitalization, Accent Microcell Ltd or Bajaj Healthcare Ltd?

Market cap of Accent Microcell Ltd is 517 Cr while Market cap of Bajaj Healthcare Ltd is 1,763 Cr

What are the key factors driving the stock performance of Accent Microcell Ltd and Bajaj Healthcare Ltd?

The stock performance of Accent Microcell Ltd and Bajaj Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accent Microcell Ltd and Bajaj Healthcare Ltd?

As of May 16, 2025, the Accent Microcell Ltd stock price is INR ₹246.0. On the other hand, Bajaj Healthcare Ltd stock price is INR ₹558.4.

How do dividend payouts of Accent Microcell Ltd and Bajaj Healthcare Ltd compare?

To compare the dividend payouts of Accent Microcell Ltd and Bajaj Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions